Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Apr;41(4):812–817. doi: 10.1128/aac.41.4.812

Mechanism of copper-mediated inactivation of herpes simplex virus.

J L Sagripanti 1, L B Routson 1, A C Bonifacino 1, C D Lytle 1
PMCID: PMC163800  PMID: 9087495

Abstract

The inactivation of herpes simplex virus (HSV) by copper was enhanced by the following reducing agents at the indicated relative level: ascorbic acid >> hydrogen peroxide > cysteine. Treatment of HSV-infected cells with combinations of Cu(II) and ascorbate completely inhibited virus plaque formation to below 0.006% of the infectious virus input, while it maintained 30% viability for the host mammalian cells. The logarithm of the surviving fraction of HSV mediated by 1 mg of Cu(II) per liter and 100 mg of reducing agent per liter followed a linear relationship with the reaction time, in which the kinetic rate constant for each reducing agent was -0.87 min(-1) (r = 0.93) for ascorbate, -0.10 min(-1) (r = 0.97) for hydrogen peroxide, and -0.04 min(-1) (r = 0.97) for cysteine. The protective effects of metal chelators and catalase, the lack of effect of superoxide dismutase, and the partial protection conferred by free-radical scavengers suggest that the mechanism of copper-mediated HSV inactivation is similar to that previously reported for copper-mediated DNA damage. The sensitivity exhibited by HSV to Cu(II) and reducing agents, particularly ascorbate, might be useful in the development of therapeutic antiviral agents.

Full Text

The Full Text of this article is available as a PDF (219.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aruoma O. I., Halliwell B., Gajewski E., Dizdaroglu M. Copper-ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. Biochem J. 1991 Feb 1;273(Pt 3):601–604. doi: 10.1042/bj2730601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berglin E. H., Edlund M. B., Nyberg G. K., Carlsson J. Potentiation by L-cysteine of the bactericidal effect of hydrogen peroxide in Escherichia coli. J Bacteriol. 1982 Oct;152(1):81–88. doi: 10.1128/jb.152.1.81-88.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Collins P., Larder B. A., Oliver N. M., Kemp S., Smith I. W., Darby G. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J Gen Virol. 1989 Feb;70(Pt 2):375–382. doi: 10.1099/0022-1317-70-2-375. [DOI] [PubMed] [Google Scholar]
  4. Darby G. Acyclovir--and beyond. J Int Med Res. 1994;22 (Suppl 1):33A–42A. [PubMed] [Google Scholar]
  5. Darby G. The acyclovir legacy: its contribution to antiviral drug discovery. J Med Virol. 1993;Suppl 1:134–138. doi: 10.1002/jmv.1890410526. [DOI] [PubMed] [Google Scholar]
  6. De Clercq E. Antivirals for the treatment of herpesvirus infections. J Antimicrob Chemother. 1993 Jul;32 (Suppl A):121–132. doi: 10.1093/jac/32.suppl_a.121. [DOI] [PubMed] [Google Scholar]
  7. Dizdaroglu M., Rao G., Halliwell B., Gajewski E. Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch Biochem Biophys. 1991 Mar;285(2):317–324. doi: 10.1016/0003-9861(91)90366-q. [DOI] [PubMed] [Google Scholar]
  8. Ellis M. N., Keller P. M., Fyfe J. A., Martin J. L., Rooney J. F., Straus S. E., Lehrman S. N., Barry D. W. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob Agents Chemother. 1987 Jul;31(7):1117–1125. doi: 10.1128/aac.31.7.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Field A. K., Biron K. K. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev. 1994 Jan;7(1):1–13. doi: 10.1128/cmr.7.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Field H. J., Darby G., Wildy P. Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. J Gen Virol. 1980 Jul;49(1):115–124. doi: 10.1099/0022-1317-49-1-115. [DOI] [PubMed] [Google Scholar]
  11. Lytle C. D. Host-cell reactivation in mammalian cells. I. Survival of ultra-violet-irradiated herpes virus in different cell-lines. Int J Radiat Biol Relat Stud Phys Chem Med. 1971;19(4):329–337. doi: 10.1080/09553007114550451. [DOI] [PubMed] [Google Scholar]
  12. McGrath B. J., Newman C. L. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome. Pharmacotherapy. 1994 Sep-Oct;14(5):529–542. [PubMed] [Google Scholar]
  13. Nathan C. F., Root R. K. Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering. J Exp Med. 1977 Dec 1;146(6):1648–1662. doi: 10.1084/jem.146.6.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. O'Brien J. J., Campoli-Richards D. M. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1989 Mar;37(3):233–309. doi: 10.2165/00003495-198937030-00002. [DOI] [PubMed] [Google Scholar]
  15. Safrin S. Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS. J Acquir Immune Defic Syndr. 1992;5 (Suppl 1):S29–S32. [PubMed] [Google Scholar]
  16. Sagripanti J. L., Goering P. L., Lamanna A. Interaction of copper with DNA and antagonism by other metals. Toxicol Appl Pharmacol. 1991 Sep 15;110(3):477–485. doi: 10.1016/0041-008x(91)90048-j. [DOI] [PubMed] [Google Scholar]
  17. Sagripanti J. L., Kraemer K. H. Site-specific oxidative DNA damage at polyguanosines produced by copper plus hydrogen peroxide. J Biol Chem. 1989 Jan 25;264(3):1729–1734. [PubMed] [Google Scholar]
  18. Sagripanti J. L., Lightfoote M. M. Cupric and ferric ions inactivate HIV. AIDS Res Hum Retroviruses. 1996 Mar 1;12(4):333–337. doi: 10.1089/aid.1996.12.333. [DOI] [PubMed] [Google Scholar]
  19. Sagripanti J. L. Metal-based formulations with high microbicidal activity. Appl Environ Microbiol. 1992 Sep;58(9):3157–3162. doi: 10.1128/aem.58.9.3157-3162.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sagripanti J. L., Routson L. B., Lytle C. D. Virus inactivation by copper or iron ions alone and in the presence of peroxide. Appl Environ Microbiol. 1993 Dec;59(12):4374–4376. doi: 10.1128/aem.59.12.4374-4376.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Samuni A., Aronovitch J., Godinger D., Chevion M., Czapski G. On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. Eur J Biochem. 1983 Dec 1;137(1-2):119–124. doi: 10.1111/j.1432-1033.1983.tb07804.x. [DOI] [PubMed] [Google Scholar]
  22. Sasadeusz J. J., Sacks S. L. Systemic antivirals in herpesvirus infections. Dermatol Clin. 1993 Jan;11(1):171–185. [PubMed] [Google Scholar]
  23. Schubert J., Wilmer J. W. Does hydrogen peroxide exist "free" in biological systems? Free Radic Biol Med. 1991;11(6):545–555. doi: 10.1016/0891-5849(91)90135-p. [DOI] [PubMed] [Google Scholar]
  24. Toyokuni S., Sagripanti J. L. Association between 8-hydroxy-2'-deoxyguanosine formation and DNA strand breaks mediated by copper and iron. Free Radic Biol Med. 1996;20(6):859–864. doi: 10.1016/0891-5849(95)02184-1. [DOI] [PubMed] [Google Scholar]
  25. Toyokuni S., Sagripanti J. L. DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis. Carcinogenesis. 1993 Feb;14(2):223–227. doi: 10.1093/carcin/14.2.223. [DOI] [PubMed] [Google Scholar]
  26. Toyokuni S., Sagripanti J. L. Increased 8-hydroxydeoxyguanosine in kidney and liver of rats continuously exposed to copper. Toxicol Appl Pharmacol. 1994 May;126(1):91–97. doi: 10.1006/taap.1994.1094. [DOI] [PubMed] [Google Scholar]
  27. Toyokuni S., Sagripanti J. L. Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron. J Inorg Biochem. 1992 Aug 15;47(3-4):241–248. doi: 10.1016/0162-0134(92)84069-y. [DOI] [PubMed] [Google Scholar]
  28. de Ruiter A., Thin R. N. Genital herpes. A guide to pharmacological therapy. Drugs. 1994 Feb;47(2):297–304. doi: 10.2165/00003495-199447020-00005. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES